Vect-Horus SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vect-Horus SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10657
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vect-Horus SAS (Vect-Horus) is a biotechnology company that designs and develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into organs including the brain and tumors. The company combines molecules of interest to peptide-vectors that targets receptor mediated transport to overcome biological barriers and reduce the attrition rate of central nervous system drugs. Its vectors target receptors including receptor mediated transport, a physiological system for the transport into cells of endogenous substances. The company provides screening platform of peptide and nanobody libraries to identify and optimize RMT-based vectors and conjugate them with molecules of organic molecules, peptides, therapeutic proteins, monoclonal antibodies and oligonucleotides. It has collaborations with other academic institutions. Vect-Horus is headquartered in Marseille, France.

Vect-Horus SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vect-Horus SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vect-Horus SAS, Medical Devices Deals, 2012 to YTD 2018 9
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vect-Horus Raises USD1.9 Million in Venture Financing 11
Vect-Horus Raises Funds through Fifth Round of Venture Financing 12
Partnerships 13
Vect-Horus Enters into Agreement with Servier 13
Sanofi Enters into Research Agreement with Vect-Horus 14
Vect-Horus Enters into Collaboration Agreement with Advanced Accelerator Applications for Radio-Imaging Agents 15
Equity Offering 16
Vect-Horus Raises USD4.1 Million in Private Placement 16
Vect-Horus Raises USD2.7 Million in Private Placement 17
Vect-Horus SAS – Key Competitors 18
Vect-Horus SAS – Key Employees 19
Vect-Horus SAS – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Sep 19, 2017: VECT-HORUS Announces the Expansion of its Scientific Advisory Board 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Vect-Horus SAS, Pharmaceuticals & Healthcare, Key Facts 2
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vect-Horus SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vect-Horus SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Vect-Horus SAS, Medical Devices Deals, 2012 to YTD 2018 9
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vect-Horus Raises USD1.9 Million in Venture Financing 11
Vect-Horus Raises Funds through Fifth Round of Venture Financing 12
Vect-Horus Enters into Agreement with Servier 13
Sanofi Enters into Research Agreement with Vect-Horus 14
Vect-Horus Enters into Collaboration Agreement with Advanced Accelerator Applications for Radio-Imaging Agents 15
Vect-Horus Raises USD4.1 Million in Private Placement 16
Vect-Horus Raises USD2.7 Million in Private Placement 17
Vect-Horus SAS, Key Competitors 18
Vect-Horus SAS, Key Employees 19

List of Figures
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vect-Horus SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vect-Horus SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vect-Horus SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Range Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Range Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and …
  • Corning Inc (GLW):医療機器:M&Aディール及び事業提携情報
    Summary Corning Inc (Corning) manufactures and sells ceramics, specialty glasses, and related materials. The company offers glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for telecommunications networks; ceram …
  • SGL Carbon SE (SGL):企業の財務・戦略的SWOT分析
    SGL Carbon SE (SGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • UnionBank of the Philippines (UBP):企業の財務・戦略的SWOT分析
    UnionBank of the Philippines (UBP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • China Food Company PLC :企業の戦略・SWOT・財務情報
    China Food Company PLC - Strategy, SWOT and Corporate Finance Report Summary China Food Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nidec Corporation:企業の戦略・SWOT・財務分析
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Heineken NV:企業の戦略・SWOT・財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Crown Castle International Corp.:企業の戦略・SWOT・財務情報
    Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report Summary Crown Castle International Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • T&D Holdings, Inc.:企業の戦略・SWOT・財務分析
    T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析
    Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company’s products include immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immun …
  • The Japan Steel Works Ltd:企業の戦略・SWOT・財務分析
    The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report Summary The Japan Steel Works Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • EnviroMission Ltd:企業の戦略的SWOT分析
    EnviroMission Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Banco BPI SA:企業の戦略・SWOT・財務分析
    Banco BPI SA - Strategy, SWOT and Corporate Finance Report Summary Banco BPI SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • Orgenesis Inc (ORGS):製薬・医療:M&Aディール及び事業提携情報
    Summary Orgenesis Inc (Orgenesis) is a biopharmaceutical company that focuses on the development and manufacturing of regenerative cellular therapy and medicine for the treatment of insulin-dependent diabetes patients. The company, through its subsidiaries, offers contract development and manufactur …
  • CIRCOR Aerospace Products Group:企業の戦略・SWOT・財務情報
    CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report Summary CIRCOR Aerospace Products Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Hologic Inc (HOLX):企業の財務・戦略的SWOT分析
    Hologic Inc (HOLX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lonza Group Ltd (LONN):企業の財務・戦略的SWOT分析
    Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • IRLAB Therapeutics AB (IRLAB A):製薬・医療:M&Aディール及び事業提携情報
    Summary IRLAB Therapeutics AB (IRL) is a pharmaceutical company that discovers and develops drugs to treat central nervous system associated diseases. The company conducts flagship technology integrative screening process, a phenotypic screening and systems pharmacology process is used for developme …
  • ULURU Inc (ULUR):医療機器:M&Aディール及び事業提携情報
    Summary ULURU Inc (ULURU) is a medical technology company that researches, develops, and markets wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆